What You Need to Know
• Researchers found that a blood test can predict Alzheimer’s risk in healthy older adults.
• The study indicated that high p-tau217 levels correlate with a 38% risk of cognitive impairment over five years.
• The findings were published in JAMA and presented at the Alzheimer’s Association International Conference in London.
Dr. Reisa Sperling, senior author and neurologist at Mass General Brigham Neuroscience Institute, announced that a blood test may help predict whether healthy older adults will develop Alzheimer’s symptoms within the next five or ten years. The p-tau217 test, which measures tau levels associated with Alzheimer’s, showed that older adults with high p-tau217 levels had a 38% risk of cognitive impairment over five years, increasing to 78% over ten years. The study analyzed data from 2,684 older adults who participated in long-term Alzheimer’s research, with findings published in JAMA. Researchers caution that it is premature for healthy individuals to seek this test, as it is primarily used for diagnosing existing cognitive issues.
Why It Matters
This research is significant as it provides a potential tool for identifying individuals at high risk for Alzheimer’s disease, which affects millions globally. Understanding the role of p-tau217 in predicting cognitive decline could enhance the enrollment of high-risk participants in clinical trials for Alzheimer’s treatments. The study’s findings contribute to ongoing efforts to develop preventive strategies and improve early diagnosis, which is crucial given the increasing prevalence of Alzheimer’s among aging populations.
Read the Full Story →
